Lewis, B. J. B., Ville, J., Blacquiere, M., Cen, S., Spirig, R., Zuercher, A. W., . . . Branch, D. R. (2019). Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer. BMC Immunol.
Citação norma ChicagoLewis, Bonnie J. B., Jade Ville, Megan Blacquiere, Selena Cen, Rolf Spirig, Adrian W. Zuercher, Fabian Käsermann, and Donald R. Branch. "Using the K/BxN Mouse Model of Endogenous, Chronic, Rheumatoid Arthritis for the Evaluation of Potential Immunoglobulin-based Therapeutic Agents, Including IVIg and Fc-μTP-L309C, a Recombinant IgG1 Fc Hexamer." BMC Immunol 2019.
MLA CitationLewis, Bonnie J. B., et al. "Using the K/BxN Mouse Model of Endogenous, Chronic, Rheumatoid Arthritis for the Evaluation of Potential Immunoglobulin-based Therapeutic Agents, Including IVIg and Fc-μTP-L309C, a Recombinant IgG1 Fc Hexamer." BMC Immunol 2019.